cgp 54626 has been researched along with vasoactive intestinal peptide in 1 studies
| Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 57 | 0 | 16 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, M; Huang, ZJ; Pfeffer, CK; Scanziani, M; Xue, M | 1 |
1 other study(ies) available for cgp 54626 and vasoactive intestinal peptide
| Article | Year |
|---|---|
Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons.
Topics: Animals; Biomarkers; Channelrhodopsins; Female; Genes, Reporter; Inhibitory Postsynaptic Potentials; Interneurons; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neural Inhibition; Optogenetics; Organophosphorus Compounds; Parvalbumins; Patch-Clamp Techniques; Photic Stimulation; Principal Component Analysis; Pyramidal Cells; Quinoxalines; Recombinant Fusion Proteins; Somatostatin; Synaptic Transmission; Vasoactive Intestinal Peptide; Visual Cortex | 2013 |